Oxidized LDL modulates Bax/Bcl-2 through the lectinlike Ox-LDL receptor-1 in vascular smooth muscle cells.
about
Radiolabelled probes for imaging of atherosclerotic plaques.Scavenger receptor structure and function in health and disease.Functional analysis and molecular dynamics simulation of LOX-1 K167N polymorphism reveal alteration of receptor activity.MicroRNA-98 rescues proliferation and alleviates ox-LDL-induced apoptosis in HUVECs by targeting LOX-1PCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL via Bcl/Bax-caspase9-caspase3 pathway.Regulation of foam cells by adenosine.LOX-1 in atherosclerosis: biological functions and pharmacological modifiers.The role of Siglec-1 and SR-BI interaction in the phagocytosis of oxidized low density lipoprotein by macrophages.New scavenger receptors and their functions in atherogenesis.Inhibitory C-type lectin receptors in myeloid cells.LOX-1 plays an important role in ischemia-induced angiogenesis of limbs.Essential Oils from Fructus A. zerumbet Protect Human Aortic Endothelial Cells from Apoptosis Induced by Ox-LDL In VitroThe discovery of LOX-1, its ligands and clinical significance.Olmesartan attenuates the impairment of endothelial cells induced by oxidized low density lipoprotein through downregulating expression of LOX-1Molecular genetics of late-onset Alzheimer's disease.Purification, crystallization and preliminary X-ray analysis of the ligand-binding domain of human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1).Deletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin.Vessel wall apoptosis and atherosclerotic plaque instability.Caveolin-3 Promotes a Vascular Smooth Muscle Contractile PhenotypeDoes C-reactive protein contribute to atherothrombosis via oxidant-mediated release of pro-thrombotic factors and activation of platelets?C-type lectin-like receptors on myeloid cells.Bcl-2 protein family: implications in vascular apoptosis and atherosclerosis.Lectin-like oxidized low-density lipoprotein receptor-1, a new promising target for the therapy of atherosclerosis?LOX-1 augments oxLDL uptake by lysoPC-stimulated murine macrophages but is not required for oxLDL clearance from plasma.Pharmacological modulation of cell death in atherosclerosis: a promising approach towards plaque stabilization?LOX-1 and obesity.LOX-1/LOXIN: the yin/yang of atheroscleorosis.Novel concepts in the genesis of hypertension: role of LOX-1.Oxidized LDL, LOX-1 and atherosclerosis.LOX-1, oxidative stress and inflammation: a novel mechanism for diabetic cardiovascular complications.Current Concepts of the Role of Oxidized LDL Receptors in Atherosclerosis.Lectin-like oxidized low-density lipoprotein receptor 1 pathways.LOX-1, OxLDL, and atherosclerosisLOX-1 and ROS, inseparable factors in the process of endothelial damage.The role of lectin-like oxidised low-density lipoprotein receptor-1 in vascular pathology.Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases.Vascular smooth muscle cell in atherosclerosis.Clinical and Preclinical Use of LOX-1-Specific Antibodies in Diagnostics and Therapeutics.Free Fatty Acids Induce Autophagy and LOX-1 Upregulation in Cultured Aortic Vascular Smooth Muscle Cells.Dyslipidemia Part 1--Review of Lipid Metabolism and Vascular Cell Physiology.
P2860
Q30577193-93B88669-686D-4E1D-89F3-6E0D0D64E5B3Q30958610-B72EB48A-2853-4369-BA0F-F6DD7041D29BQ33413089-CA571AC1-E691-44E7-80C4-51C012E9D734Q33724036-10FA0A2A-D28A-442E-ABED-C6C0E7DCA9E6Q33994685-5E516896-2FEE-4908-B306-77E1F9320D27Q34031160-0E206141-8DF8-45AA-A23D-E91C4C2040C9Q34079451-FD5FF708-F199-4277-8263-CAB337C9EC43Q34631933-16B191CF-8A17-43B0-B437-3EA6E8CB59C9Q34674199-9C7B1794-B342-41AF-9228-C51122443CEAQ34700805-DC838AE9-572F-4F51-90EF-3DF1356E7C5FQ34712581-B6F47376-B52B-4C52-8003-0BB7B2FC8E2CQ34909127-A1953F1F-0126-43B0-AFF7-B537FAD3CD58Q35475499-D91874C4-3299-4C2B-8A37-E00EC022ED75Q35795742-5E7045A6-FE57-4375-9299-ADF5C30DB005Q35821959-C257FF18-0CB5-4BC2-9BA6-A4EF0CCEF6CDQ35950665-7099E684-747D-4222-918F-D8E3F36BA25FQ36022217-615BF3C6-A740-4306-9BEE-172CEA8AA737Q36062157-874FC57A-2D8B-438C-A397-C6DE23D62037Q36351159-78B7C40A-8700-4E90-B760-7E3F482F7F4EQ36403750-1632CF21-30F1-4B2B-884F-076B4580575BQ36497532-94CDA527-CE9C-44A2-8127-B456F771BB0BQ36585106-74DCD594-CEC1-4162-BF4E-BEA27ACD53F9Q36872076-FFE8690C-DB05-4BD1-B709-713B3354DC23Q37297831-A44E6167-E827-459A-9F56-F7DBE000F829Q37854817-9F475552-9A5A-46C0-8858-D61FAF93B928Q37924630-D3A56AE3-B903-4A6E-BB8B-823359073842Q37929625-EE24AB42-FE46-498E-AB92-0542AFB969EAQ37931043-365FCC5C-94EA-42B3-B754-E847C1692FB7Q37938848-7AF2D154-A2F0-4505-9314-00B3CF67FA79Q37945097-DA844EF7-DE6E-40D8-B94F-2D4FC0AC8827Q37979643-299A6875-813A-44A2-8BA9-78FA4063B3A6Q38099693-BFB72A4F-8954-4F89-9D0C-9B4FEC2E7EB3Q38128283-3630B40F-9E48-4540-A9D4-5ADA3F99133EQ38216728-499A47CA-7FCC-4A2B-9372-D8CC002DBD55Q38248729-A3AD8CC6-93A6-470D-875E-8E1EBF0FAC54Q38299279-30595216-4C74-42F5-8027-5CCCEE4FD304Q38353932-12375FA7-521F-4198-88F1-202E61EADC4FQ38589168-24D78C12-5880-41BF-A374-E4C13CA72935Q38722117-DD6861E8-916F-4F23-8468-7FD8D4974F7EQ38777318-8BB69CFE-4EBE-4864-B64F-D43B19CF1382
P2860
Oxidized LDL modulates Bax/Bcl-2 through the lectinlike Ox-LDL receptor-1 in vascular smooth muscle cells.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Oxidized LDL modulates Bax/Bcl ...... vascular smooth muscle cells.
@en
Oxidized LDL modulates Bax/Bcl ...... vascular smooth muscle cells.
@nl
type
label
Oxidized LDL modulates Bax/Bcl ...... vascular smooth muscle cells.
@en
Oxidized LDL modulates Bax/Bcl ...... vascular smooth muscle cells.
@nl
prefLabel
Oxidized LDL modulates Bax/Bcl ...... vascular smooth muscle cells.
@en
Oxidized LDL modulates Bax/Bcl ...... vascular smooth muscle cells.
@nl
P2093
P356
P1476
Oxidized LDL modulates Bax/Bcl ...... vascular smooth muscle cells.
@en
P2093
Hashimoto N
Hayashida K
Miyamoto S
Morimoto M
P304
P356
10.1161/01.ATV.21.6.955
P407
P577
2001-06-01T00:00:00Z